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Human UMP synthase is a bifunctional protein con-
taining two separate catalytic domains, orotate phos-
phoribosyltransferase (EC 2.4.2.10) and orotidine-5*-
phosphate decarboxylase (EC 4.1.1.23). These studies
address the question of why the last two reactions in
pyrimidine nucleotide synthesis are catalyzed by a bi-
functional enzyme in mammalian cells, but by two sep-
arate enzymes in microorganisms. From existing data
on subunit associations of the respective enzymes and
calculations showing the molar concentration of en-
zyme to be far lower in mammalian cells than in micro-
organisms, we hypothesize that the covalent union in
UMP synthase stabilizes the domains containing the re-
spective catalytic centers. Evidence supporting this hy-
pothesis comes from studies of stability of enzyme activ-
ity in vitro, at physiological concentrations, of UMP
synthase, the two isolated catalytic domains prepared
by site-directed mutagenesis of UMP synthase, and the
yeast ODCase. The two engineered domains have activ-
ities very similar to the native UMP synthase, but unlike
the bifunctional protein, the domains are quite unstable
under conditions promoting the dissociated monomer.
The final two steps in the de novo biosynthesis of UMP
require the addition of ribose-P to the pyrimidine base orotate
by orotate phosphoribosyltransferase (OPRTase)1 to form OMP
and the subsequent decarboxylation of OMP to form UMP by
orotidylate decarboxylase (ODCase). In all microorganisms ex-
amined, these two catalytic centers are coded by two separate
genes, while in all multicellular eukaryotes examined, the
genes for these two catalytic centers have been joined into a
single gene, resulting in the expression of the bifunctional
protein, UMP synthase, with two different catalytic domains
(1) (Fig. 1A).
Monomeric UMP synthase can be converted to a simple
dimer, with an s20,w of 5.1, by various anions such as phos-
phate, and to a faster sedimenting 5.6 S dimer with optimal
activity by the normal ligand, OMP, or by nucleotide analogs (2,
3) (Fig. 1B). An important feature of this model is that there are
two conformational states of the dimer, based on sedimentation
studies showing that only nucleotides produced the more rap-
idly sedimenting 5.6 S species (2, 3), on studies showing that a
different type of tryptic digestion pattern for the pure enzyme
was obtained in the presence of these tight binding nucleotides,
than in the presence of simple anions (4), and on studies show-
ing that enzyme preincubated to be in the 5.6 S form had
optimum activity immediately after the addition of substrate,
while enzyme preincubated in the 5.1 S form had a 20-s lag
time after substrate addition before attaining optimum activity
(5). Such conformational features have been found for a large
set of dissociating enzymes, whose diagnostic feature is the
reversible interconversion between monomeric and oligomeric
forms, which occurs in response to physiological concentrations
of appropriate regulatory effectors (6).
Three different important benefits are likely candidates for
the evolution of the bifunctional architecture: 1) the two cata-
lytic centers may interact to “channel” the intermediate OMP;
2) an element of allosteric control is jointly communicated
between the two different domains; 3) the intact bifunctional
protein is more stable than the separated catalytic domains.
Channeling of intermediate metabolites between catalytic cen-
ters remains a controversial topic as shown in a recent sympo-
sium (7), with channeling being supported with some enzymes
but not for others. Our earlier studies had tested the channel-
ing hypothesis for UMP synthase with mouse cell extracts,
which would contain normal quantities of enzymes that might
compete for any OMP being formed by the OPRTase domain of
UMP synthase (8). These studies showed that channeling was
not efficient, since part of the OMPmade by UMP synthase was
readily converted to orotidine by an available phosphatase
activity, thereby verifying that some OMP had to have diffused
into the bulk solvent during the assay.
There is better support for the other two benefits, since the
dimerization of UMP synthase in response to effectors results
in better activity for each catalytic domain as suggested in Fig.
1 (2, 3, 5, 9). Also, such an architecture could serve to enhance
the stability of the enzyme as a monomer or as a dimer. This
latter benefit was suggested by the observation described in the
text that the intracellular concentrations of monofunctional
OPRTase and ODCase in microorganisms are 10–100-fold the
concentration of the bifunctional UMP synthase in mammalian
cells and was verified by the experiments described.
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EXPERIMENTAL PROCEDURES
Materials—The following materials were obtained from the indicated
sources: sodium [7-14C]orotate and sodium [7-14C]OMP (DuPont NEN);
polyethylene glycol, molecular weight 10,000 (Fluka); dithiothreitol,
ultrapure (Boehringer Mannheim); 98–99% pure bovine serum albumin
(Sigma). The yeast ODCase used was either the 60–90% ammonium
sulfate fraction (for the radioactive assays) or the pure enzyme (for the
spectrophotometric assays) produced using the method of Bell and
Jones (10). All other chemicals were reagent grade or as specified in the
appropriate references.
Construction and Expression of Plasmids—Plasmid pAcUMPS con-
taining the coding region for UMP synthase (11) was used as a polym-
erase chain reaction template for construction of plasmids. With the
OPRTase domain at the 59-end, the plasmid was cut at a unique NheI
site 57 codons into the downstream region of the ODCase domain.
These extra codons of the ODCase domain were removed by a loop-out
mutagenesis using a primer which placed the stop codon immediately
after the codon for glycine 213 of the OPRTase domain in plasmid
pAcOPRT. Mutagenesis was according to the method of Kunkel (12)
utilizing the single-stranded DNA produced by phage M13m19.
Plasmid pAcODC was constructed by making a polymerase chain
reaction copy of the ODCase coding region beginning at isoleucine 218.
A primer was designed to change isoleucine to methionine while incor-
porating the methionine codon into a new NcoI site. The polymerase
chain reaction product was trimmed withNcoI and ligated intoNcoI cut
pAcUMPS. Plasmids of the correct sequence were identified by restric-
tion analysis and confirmed by sequencing the DNA across the N-
terminal junction. Recombinant plasmids were grown in Escherichia
coli and purified by CsCl gradient centrifugation in preparation for the
production of recombinant baculoviruses. Thereafter, cabbage looper
larvae were injected with recombinant baculovirus as reported previ-
ously (11). After injection into the larvae, the expression of the proteins
was followed by Western blots and activity assays with larval extracts,
and optimum expression occurred at 5 days post-infection.
Purification of Expressed UMP Synthase and the Two Domains—The
expressed UMP synthase, K314C variant, and ODCase domain were
purified on a monoclonal antibody affinity column (11). Homogenates of
cabbage looper larvae producing each protein were made using the
same protocol except that the larvae were homogenized in the standard
buffer, adjusted to pH 6.8 (at 0 °C) and containing 25% ammonium
sulfate. The ODCase domain and OPRTase domain were precipitated at
65% ammonium sulfate saturation. After storage of the ammonium
sulfate pellet, OPRTase was further purified by specific elution from a
phosphocellulose column. The sample was diluted 25-fold in buffer (20
mM MOPS, 1 mM EDTA, pH 6.8) and loaded onto the column (10 ml).
The column was then washed with 100 ml of buffer, 50 ml of buffer
containing 0.05 M KCl followed by 50 ml of buffer, and the last two
washes were repeated until the absorbance at 280 nm was unchanged.
The OPRTase domain was then eluted with 50 ml of buffer containing
0.04 M KCl and 0.1 mM OMP. Elution fractions were concentrated in an
Amicon ultrafiltration cell to a volume of about 8 ml, then in a collodion
bag for about 5 h versus collodion dialysis buffer 2 (11). Protein concen-
trations were determined by the method of Bradford (13).
Enzyme Assays—ODCase activity was determined at 25 or 37 °C by
measuring the release of 14CO2 from [
14C]OMP as described previously
(14) or by a spectrophotometric assay measuring the decrease in ab-
sorbance at 285 nm for the conversion of OMP to UMP (11). OPRTase
activity was determined at 25 or 37 °C by measuring the release of
14CO2 from [
14C]orotate after sequential conversion to OMP and UMP
1 14CO2 or by a spectrophotometric assay measuring the decrease in
absorbance at 295 nm for the conversion of orotate to OMP and to UMP
(11). Changes to these standard protocols are given under Results or in
figure legends. For assays of the OPRTase domain in the forward
reaction, an equimolar amount of the human ODCase domain was
added to ensure conversion of OMP to UMP 1 CO2. The specific activ-
ities of the [14C]OMP or [14C]orotate in the reaction mixtures were
determined by adding large excesses of UMP synthase to allow total
conversion of the substrate. Enzyme dilutions were made prior to use in
the standard buffer.
Enzyme activity for the Arrhenius plots was measured spectropho-
tometrically, with the temperature controlled by a thermo-electric cu-
vette holder. Enzyme was added at a concentration of 10–15 mg/ml, and
substrate concentrations were at 100 mM orotate plus 0.3 mM P-Rib-PP
for the forward OPRTase reaction or at 100 mM OMP plus 1.2 mM PPi for
the reverse OPRTase activity or at 200 mM OMP for ODCase activity.
Sucrose Density Gradient Centrifugation—Experiments were gener-
ally performed as described previously (15). Gradients (10 ml of a
10–40% sucrose solution containing 10% glycerol) were made in stand-
ard buffer: 50 mM Tris-HCl, pH 7.5, 2 mM EDTA, and 5 mM dithiothre-
itol. Gradients were layered with a 200-ml enzyme sample containing
enzyme protein, plus Mr standards. Many gradients also contained
effector ligands at specified concentrations, based on the previously
determined affinity of such ligands for the enzyme.
Calculations—Estimates of the concentration in vivo of the bifunc-
tional UMP synthase or of the monofunctional ODCase and OPRTase




~g total tissue 3 0.8 ml/g!/~Mr 3 1026!
(Eq. 1)
where SA is the specific activity of pure enzyme, and the cytoplasmic
volume of tissue is approximately 0.8 ml/g for three different mamma-
lian tissues (16–18).
RESULTS AND DISCUSSION
Preparing the Separate Domains—The current data base
shows the consensus sequence for 16 monofunctional OPRT-
ases from bacteria and fungi does not extend beyond residue
208 of UMP synthase (480 amino acids total), while a sequence
alignment with 31 monofunctional ODCases suggests that the
consenus structure for the ODCase domain begins after amino
acid 224. To ensure producing complete domains, we engi-
neered a plasmid with the sequence for the human UMP syn-
thase to produce truncated cDNAs for the OPRTase domain
ending at residue 214 and for the ODCase domain beginning at
residue 218. Recombinant baculoviruses for the complete UMP
synthase and for both the OPRTase and ODCase domain ex-
pressed proteins of the expected size, and these domains were
specifically recognized in a Western blot by a polyclonal anti-
body raised against human UMP synthase (data not shown).
Activities—When these protein domains were purified, they
showed enzymatic activity very similar to that observed with
the bifunctional protein. These are the first studies that have
determined both the absolute rates and the Km values for each
catalytic center with the bifunctional UMP synthase, as well as
with the separated domains (Table I). For the OPRTase, the Km
for orotate with the bifunctional human UMP synthase is 2.1
mM, a value almost the same as measured with the same en-
zyme from mouse (3). The OPRTase domain has a somewhat
higher Km of 7.1 mM.
The human ODCase has a Km of 230 nM for OMP, a value
very similar to earlier measurements for the mammalian en-
zyme (5, 19). By comparison the human ODCase domain had a
slightly higher Km of 295 nM. These results verify that the
domains, produced by our changes of the human UMP synthase
cDNA, behave as if they are properly folded proteins with
normal enzymatic rates and affinities for substrates.
Dimerization of UMP Synthase—Since earlier studies with
the mammalian UMP synthase and the yeast ODCase had
demonstrated the allosteric response of these enzymes to effec-
tor ligands as measured by the association of monomers to form
the dimer (2, 3, 10, 15), sedimentation studies were done with
the pure human UMP synthase. This conformational response
to allosteric ligands was readily measured with the pure en-
zyme: UMP synthase at concentrations below 15 nM was very
stable as a monomer, and it generally took enzyme concentra-
TABLE I
Specific activities and substrate affinities at 37 °C for the bifunctional
UMP synthase and the separate catalytic domains
Enzyme species k Substrate: Km
s21
OPRTase-bifunctional: 4.0 Orotate: 2.1 6 0.12 mM
OPRTase domain: 2.9 Orotate: 7.1 6 0.27 mM
ODCase-bifunctional: 16 OMP: 230 6 8.7 nM
ODCase domain: 13 OMP: 295 6 18 nM
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tions $ 100 nM to produce association to the dimer in the
absence of an effector nucleotide ligand (data not shown). How-
ever, at enzyme concentrations of about 10 nM, the presence of
various high affinity nucleotides produced the conformational
change that stabilized the dimer form. The tight binding inhib-
itor nucleotide barbiturate riboside monophosphate (Ki 5 4.1
nM) produced complete dimerization at a concentration equal to
the enzyme.
Dependence of Catalytic Rates on Temperature—The effect of
temperature on OPRTase and ODCase catalytic activities was
tested with enzyme at concentrations of 230–640 nM and sub-
strates at 100 mM. These optimal concentrations are far above
the physiological concentrations for the enzyme (Table II), or
the Km values determined for their substrates (Table I). The
measured enthalpy was DH 5 9.7 kcal/mol for the forward
OPRTase reaction (orotate3 OMP) when measured with UMP
synthase, or with the separated OPRTase domain, and DH 5
21.7 kcal/mol for the reverse OPRTase reaction (OMP 3 oro-
tate). This difference in the intrinsic energy for this reaction,
depending on direction, is completely consistent with earlier
results showing that the reverse reaction is kinetically more
favorable than the forward reaction (3). For the ODCase reac-
tion DH 5 14.9 kcal/mol when measured with UMP synthase or
with the separated ODCase domain. These temperature stud-
ies for both reactions also demonstrate that under optimized
experimental conditions there is no difference in the observed
activity for the reaction as measured with the bifunctional
UMP synthase and the separate OPRTase or ODCase domain,
signifying that under these conditions the isolated proteins are
stable and completely active at the temperatures used, and for
the times used.
Thermal Stability of the Two Catalytic Centers—Since the
above experiments were done under conditions that are clearly
not completely physiological, additional studies were done to
properly assess the bifunctional protein and the two separate
domains under conditions that could explore their stability as a
function of protein concentration, which influences whether the
enzyme is a monomer or a dimer. ODCase activity could be
reliably measured at about 10 pM. At this low concentration of
enzyme, it was also possible to use an initial substrate concen-
tration near Km, so that the enzyme would not be saturated
with bound substrate and thus increase the detection of insta-
bility since part of the enzyme population would remain un-
bound to ligand and therefore in the monomeric form at all
times (Fig. 1). To compare the different progress curves, data
are therefore presented as the percent substrate converted to
product.
The ODCase activity of the bifunctional UMP synthase at
this low protein concentration remains constant for 40 min at
25 °C (Fig. 2A), and at 37 °C declines very slightly after about
15 min when more than 10% of the substrate has been de-
pleted. At this low concentration of enzyme, the ODCase do-
main is much less stable, and the progress curve becomes
nonlinear after only 2 min at either 25 °C or at 37 °C, before
any significant depletion of substrate has occurred (Fig. 2B).
While the ODCase domain and the bifunctional ODCase have
inherently similar activities under optimal conditions where
the enzymes are dimeric, in the experiment of Fig. 2 it is
readily apparent that when the ODCase domain is diluted
enough to keep the enzyme partly monomeric, its intrinsic
activity is the same as the activity in UMP synthase for about
the first 2 min, whereafter it becomes much lower than that of
the UMP synthase.
The yeast ODCase is even more unstable than the human
ODCase domain, and activity declined after only 1 min, and the
decline in activity at 37 °C was more dramatic (Fig. 3). Also, the
yeast ODCase showed much lower total activity at 37 °C, con-
sistent with increased protein instability at this temperature.
Similar stability experiments were done with the OPRTase
reaction, but with protein at a concentration of 100 pM to
ensure reproducible measurements. For the OPRTase in UMP
TABLE II
Estimated concentrations in vivo of UMP synthase (UMPS) and the







Human placenta 17 19
Human lymphocytes 32 27
Rat liver 11 28
Rat brain 27 29
Microorganisms:
E. coli 2900 26
E. coli 2720 24
Yeast 950 260 22
Yeast 375 30
FIG. 1. Genes and possible structures for UMP synthase. A,
natural gene fusion led to the fusion of catalytic domains. B, conforma-
tional states: phosphate and anionic analogs promote association of
inactive subunits to the simple dimer, as measured by sedimentation.
OMP, or nucleotide analogs, produce an additional conformational
change, measured by increased sedimentation and necessary for opti-
mum enzyme activity. E 5 inactive; l 5 partly active; * 5 active.
FIG. 2. Stability of the dilute human ODCase catalytic center.
Enzyme at a final concentration of 10.5 pM was incubated for the time
shown with the substrate OMP at 230 nM, at 37 °C (closed symbols) or
at 25 °C (open symbols).
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synthase, enzyme activity remained linear and stable at both
temperatures and for the full 40-min time period (Fig. 4A).
Since our initial studies showed that the OPRTase domain was
a little less active under these experimental conditions, it was
assayed with the domain at a concentration of 1.0 nM. Though
at a 10-fold higher concentration than UMP synthase, the
OPRTase domain’s activity was not linear at 37 °C or at 25 °C
(Fig. 4B). While the diluted ODCase domain appeared to be
equally unstable at 37 °C or at 25 °C (Fig. 2B), the OPRTase
domain appeared more unstable at the lower temperature
(Fig. 4B).
To test these activities at physiological concentrations of
enzyme, an effort was made to estimate what these concentra-
tions might be, by using data from published purification re-
sults (see “Experimental Procedures”). It is apparent that in
four normal mammalian tissues, the bifunctional UMP syn-
thase has cellular concentrations estimated to be in the 11–32
nM range (Table II). By comparison, mitotically active tumor
cells have increased the concentration of this important bifunc-
tional protein by about 10-fold or more (20, 21), while microor-
ganisms have concentrations of the separate catalytic enzymes
that are very much higher (Table II). Therefore, additional
stability experiments were done with enzyme concentrations at
40 nM, a value at the upper end of normal physiological con-
centrations in mammals.
The stability experiment at these higher enzyme concentra-
tions had to be modified, since activity cannot be maintained
for such long time periods (40 min) at low substrate concentra-
tions. Therefore, enzyme at a final concentration of about 40 nM
was preincubated in buffer for either one minute, or for 40 min,
at which time substrate was added to a concentration $ 50 3
Km, and continuous activity was monitored after the addition of
substrate at 0 min to the preincubated enzyme (Fig. 5). When
either UMP synthase or the human ODCase domain was pre-
incubated for 1 min, there was no detectable change in enzyme
activity: the progress curves were linear until more than 30% of
the substrate had been depleted. However, when the enzyme
samples had been preincubated at 25 °C for 40 min in the
absence of any ligands, there was about a 20% decline in the
rate of the initial progress curve, and this decline was compa-
rable for the bifunctional UMP synthase and for the ODCase
domain.
The OPRTase domain, by comparison, was more unstable
even at these higher concentrations (40 nM). The 1-min prein-
cubation had no dramatic effect on the activity, and the curva-
ture evident in Fig. 6 reflects the sensitivity of this assay to the
accumulation of products and the possibility of the back reac-
tion. However, when these same enzyme samples had been
preincubated for 40 min, the bifunctional protein showed a
modest decrease in the initial rate of activity, while the sepa-
rate OPRTase domain had no detectable activity when main-
tained at 25 °C for 40 min in the absence of any ligands. This
dramatic loss of activity was very reproducible. Separate ex-
periments (not shown) gave no evidence for proteolysis produc-
ing the total loss of enzyme activity seen for the OPRTase in
Fig. 6.
Although earlier studies with UMP synthase had noted the
instability of the OPRTase activity, this difficulty was resolved
by optimizing the storage and assay buffers as recently de-
FIG. 4. Stability of the dilute human OPRTase catalytic center.
Enzyme at a final concentration of 100 pM (A) or at 1.0 nM (B) was
incubated for the time shown with the substrate orotate at 2.0 mM, at
37 °C (closed symbols) or at 25 °C (open symbols).
FIG. 5. Stability of concentrated ODCase at 25 °C. Enzyme at a
final concentration of 40 nM was initially preincubated for 1 min using
UMP synthase (OO) or ODCase domain (— ———), or for 40 min.
with UMP synthase (— – — – —) or ODCase domain (– – – –). After the
preincubation period, enzyme activity was then initiated by the addi-
tion at 0 min of the substrate OMP at 200 mM.
FIG. 6. Stability of concentrated OPRTase at 25 °C. Enzyme at a
final concentration of 40 nM was initially preincubated for 1 min using
UMP synthase (OO) or OPRTase domain (— ———) or for 40 min
with UMP synthase (— – — –) or OPRTase domain (– – – –). Activity
was then initiated by the addition at 0 min with the substrate orotate
at 100 mM and P-Rib-PP at 300 mM.
FIG. 3. Stability of dilute yeast ODCase. Enzyme at a final con-
centration of 10.1 pM was incubated with the substrate OMP at 700 nM,
at 37 °C (f) or at 25 °C (M).
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scribed (11). This improved stability of the OPRTase activity in
the bifunctional native protein is now evident in Fig. 4A.
In the experiments of Figs. 2–4, enzyme was used at a very
low concentration to ensure that the protein would be mono-
meric in the absence of ligands, and the initial concentration of
the substrate, OMP or orotate, was near Km so that a signifi-
cant fraction of the enzyme population would remain ligand-
free at any time and therefore be in the monomeric state.
Under these conditions, as a function of time in the assay,
enzyme molecules should alternate between the monomer and
active dimer states (Fig. 1). As shown by the results of Figs. 2B
and 3, the isolated human ODCase domain, as well as the yeast
ODCase monofunctional protein, were very unstable under
conditions that favored the monomeric state. Fig. 4B shows a
comparable instability for the OPRTase domain, at a concen-
tration where it would be expected to be monomeric for part of
the assay time. Thus, the data of Figs. 2A and 4A are remark-
able in demonstrating the complete stability of each catalytic
center when it is in the bifunctional architecture, even when
UMP synthase was partly in the monomeric form. A possible
explanation for the evident stability of the ODCase and
OPRTase centers of the bifunctional UMP synthase is that
there may be interaction between the two different domains
within the same subunit, as modeled in Fig. 1. Even if such
interaction between the OPRTase and ODCase domains is
transient, it could add sufficient stabilization to maintain the
active structural conformation of each domain during the time
that the protein subunit is monomeric, so that there is no
measurable loss of activity. By comparison, both the separate
human ODCase domain, the yeast ODCase, and the separate
human OPRTase domain were unstable at concentrations ex-
pected to favor the monomeric state, as measured by dramatic
loss of activity in only a few minutes under otherwise benign
conditions.
It is clear that the independent forms of OPRTase and
ODCase in bacteria and yeast must function successfully, so
that the instability observed here was more pronounced due to
the experimental conditions. However, the lower cellular con-
centration for the mammalian UMP synthase (Table II) is not
a simple benefit of UMP synthase having more efficient cata-
lytic centers. The opposite is true, since both OPRTases and
ODCases from microorganisms have intrinsic activities that
may be up to 6 or 8 times as fast as the UMP synthase values
in Table I. Calculated values for kcat of OPRTase from bacteria
or yeast are 12–32 s21 (22–25), and the values for ODCase from
microorganisms are 37–108 s21 (10, 26). Our studies show that
UMP synthase becomes a dimer at an enzyme concentration $
100 nM, while at a concentration of 750 nM yeast ODCase
remains monomeric (data not shown). Thus, even though they
are catalytically more efficient, the much larger cellular con-
centration for these enzymes in microorganisms may in part be
necessary for stability. At such cellular concentrations, the
monofunctioal OPRTase and ODCase enzymes would be pre-
dominantly or totally in the more stable and active dimeric
conformation. By comparison, the bifunctional UMP synthase
does not need to be dimeric for stability, since interaction
between domains within a subunit may serve a similar func-
tion, such that both catalytic centers of UMP synthase remain
stable under conditions where the separated domains lose
activity.
In addition to the present studies demonstrating that stabil-
ity is a benefit of the bifunctional architecture, the extent to
which OMP channeling may occur remains to be explored.
While our earlier studies with cell extracts showed that chan-
neling of OMP was incomplete (8), with the availability of pure
UMP synthase and the two domains, future studies will com-
pare the efficiency of OMP transfer within the bifunctional
enzyme in comparison to a mixture of the two domains.
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